COM:SEQUANAMEDICAL
Sequana Medical NV
- Stock
Last Close
0.85
25/11 08:49
Market Cap
40.33M
Beta: -
Volume Today
3.44K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|
net income | -11.56M - | -13.97M 20.92% | -8.23M 41.14% | -13.98M 70.00% | -14.98M 7.11% | -19.11M 27.57% | -23.62M 23.60% | -30.76M 30.27% | -32.56M 5.85% | |
depreciation and amortization | 46.54K - | 80.10K 72.12% | 77.91K 2.74% | 80.77K 3.67% | 244.09K 202.21% | 306.52K 25.58% | 408.54K 33.28% | 311.51K 23.75% | 661K 112.19% | |
deferred income tax | -0.00 - | 0.01 536,870,950% | 18.55K 185,519,921.42% | 127.13K 585.24% | 120.62K 5.12% | 171.33K 42.04% | ||||
stock based compensation | 11.50K - | 9.55K 16.91% | 22.95K 140.20% | 240.56K 948.27% | 389.16K 61.77% | 255.86K 34.25% | 536.39K 109.64% | 564.44K 5.23% | ||
change in working capital | 82.68K - | 1.15M 1,288.56% | -1.04M 190.77% | 2.88M 376.87% | -5.14M 278.27% | 371.13K 107.22% | -1.73M 566.44% | 473.68K 127.36% | -965K 303.72% | |
accounts receivables | -791.18K - | 383.87K 148.52% | -163.49K 142.59% | -456.62K 179.30% | -543K 18.92% | |||||
inventory | -622.29K - | 207.65K 133.37% | 555.96K 167.74% | 80.00K 85.61% | -362.20K 552.75% | 125.97K 134.78% | -864.87K 786.58% | 42.42K 104.90% | 483K 1,038.69% | |
accounts payables | -3.92M - | -116.86K 97.02% | -662.24K 466.69% | 990.00K 249.49% | -905K 191.41% | |||||
other working capital | 704.97K - | 940.36K 33.39% | -1.60M 269.93% | 2.80M 275.53% | -68.06K 102.43% | -21.85K 67.89% | -40.48K 85.21% | -102.11K 152.27% | ||
other non cash items | 156.45K - | -10.68K 106.83% | 788.40K 7,481.86% | 883.03K 12.00% | 877.84K 0.59% | 1.05M 19.25% | 612.54K 41.49% | 1.93M 215.34% | 2.88M 48.89% | |
net cash provided by operating activities | -11.26M - | -12.75M 13.22% | -8.38M 34.28% | -9.88M 17.87% | -18.48M 87.16% | -17.01M 7.99% | -23.62M 38.88% | -27.48M 16.36% | -29.99M 9.13% | |
investments in property plant and equipment | -88.81K - | -214.69K 141.74% | -6.52K 96.96% | -38.62K 492.71% | -333.02K 762.27% | -138.02K 58.56% | -325.78K 136.04% | -676.74K 107.73% | -711K 5.06% | |
acquisitions net | ||||||||||
purchases of investments | -19.27K - | -2.34K 87.87% | -3.79K 62.01% | -16.26K 329.35% | -4K 75.40% | -4.01K 0.35% | -12.42K 209.42% | -11K - | ||
sales maturities of investments | 23.64K - | |||||||||
other investing activites | -0.01 - | 1 - | 1K - | |||||||
net cash used for investing activites | -108.08K - | -217.03K 100.80% | -10.30K 95.25% | -54.88K 432.66% | -337.02K 514.05% | -142.03K 57.86% | -338.20K 138.12% | -653.09K 93.11% | -721K 10.40% | |
debt repayment | -1.67M - | -3.20M 91.99% | -335.37K 89.52% | -9.63M 2,770.30% | -982K 89.80% | |||||
common stock issued | 8.24M - | 7.88M 4.33% | 9.81M 24.50% | 1.59K 99.98% | 26.16M 1,644,452.92% | 19.00M 27.38% | 22.77M 19.85% | 28.42M 24.81% | 15.79M 44.45% | |
common stock repurchased | ||||||||||
dividends paid | ||||||||||
other financing activites | -21.77K - | 4.36M 20,110.67% | -314.33K 107.22% | 9.47M 3,112.09% | -1.28M 113.51% | 6.83M 633.98% | -1 100.00% | 18.53M 1,853,043,300% | -414K 102.23% | |
net cash used provided by financing activities | 8.22M - | 12.24M 48.92% | 9.50M 22.38% | 9.47M 0.32% | 23.22M 145.19% | 22.63M 2.53% | 22.44M 0.86% | 37.32M 66.36% | 14.39M 61.45% | |
effect of forex changes on cash | 485.11K - | 96.68K 80.07% | -225.58K 333.32% | 94.63K 141.95% | -129.78K 237.14% | -53.60K 58.70% | 104.34K 294.66% | 85.16K 18.39% | 32.04K 62.37% | |
net change in cash | -2.66M - | -629.51K 76.37% | 886.37K 240.80% | -366.13K 141.31% | 4.27M 1,265.91% | 5.43M 27.20% | -1.42M 126.07% | 9.27M 755.11% | -16.29M 275.65% | |
cash at beginning of period | 4.09M - | 1.43M 65.12% | 797.46K 44.12% | 1.68M 111.15% | 1.32M 21.74% | 5.59M 323.96% | 11.02M 97.19% | 9.60M 12.85% | 18.87M 96.61% | |
cash at end of period | 1.43M - | 797.46K 44.12% | 1.68M 111.15% | 1.32M 21.74% | 5.59M 323.96% | 11.02M 97.19% | 9.60M 12.85% | 18.87M 96.61% | 2.58M 86.31% | |
operating cash flow | -11.26M - | -12.75M 13.22% | -8.38M 34.28% | -9.88M 17.87% | -18.48M 87.16% | -17.01M 7.99% | -23.62M 38.88% | -27.48M 16.36% | -29.99M 9.13% | |
capital expenditure | -88.81K - | -214.69K 141.74% | -6.52K 96.96% | -38.62K 492.71% | -333.02K 762.27% | -138.02K 58.56% | -325.78K 136.04% | -676.74K 107.73% | -711K 5.06% | |
free cash flow | -11.35M - | -12.96M 14.22% | -8.38M 35.32% | -9.91M 18.24% | -18.82M 89.79% | -17.14M 8.89% | -23.94M 39.67% | -28.16M 17.61% | -30.70M 9.04% |
All numbers in EUR (except ratios and percentages)